Levetiracetam, oral and IV: continuity of supply for a chronic antiepileptic therapy.
Levetiracetam is a chronic therapy. An unplanned gap in supply is a clinical event, not just a stock-out. Near-complete oral bioavailability lets the IV concentrate and the tablet convert milligram for milligram, which is what makes hospital IV-to-oral switching straightforward. 250mg and 1000mg tablets from the M Care roster; wider strengths sourced to order.
250mg and 1000mg film-coated tablets · SV2A-binding antiepileptic mechanism · oral and IV clinical profile · CTD dossier on file.
Active ingredient
Levetiracetam, the (S)-enantiomer of etiracetam, supplied as the pure compound rather than a salt. It binds synaptic vesicle glycoprotein 2A (SV2A) and modulates neurotransmitter release, a mechanism distinct from the sodium-channel-blocking or GABA-ergic actions of most older antiepileptics. Minimal hepatic metabolism and negligible CYP-enzyme interaction gives it a comparatively clean pharmacokinetic profile against a formulary of other antiseizure medicines.
Strengths stocked
250mg and 1000mg film-coated tablets sit on the M Care roster today. Levetiracetam is also widely available worldwide as 500mg and 750mg tablets, an oral solution and a concentrate for solution for infusion; tell us the exact strength and form and we source it against the enquiry from the wider Indian WHO-GMP manufacturer base.
Indications
Partial-onset (focal) seizures, as monotherapy and as adjunctive therapy, with or without secondary generalisation; adjunctive therapy for myoclonic seizures in juvenile myoclonic epilepsy; adjunctive therapy for primary generalised tonic-clonic seizures in idiopathic generalised epilepsy. Licensed age ranges differ by indication and destination-country labelling.
Storage
No special storage precautions beyond normal room conditions for the film-coated tablet, per standard manufacturer labelling, a genuinely low-maintenance line for a pharmacy store compared with light- or temperature-sensitive antiepileptics. The oral solution and IV concentrate follow the specific product's own storage instructions.
Shelf life
Typically 24 to 36 months from manufacture, depending on the manufacturer and pack; the specific product label and Certificate of Analysis carry the exact figure. Minimum remaining shelf life at dispatch is confirmed on the order, which matters more for a maintenance therapy than for a one-off course.
Pack format
Film-coated tablets in PVC/PVdC-aluminium blister, calendar-marked packs suited to monthly hospital and community dispensing, plus HDPE bottles for tender bulk. Destination-language carton and leaflet, batch and expiry coded for tender traceability and for tracking continuity across repeat orders.
NHS trusts, MoH tender desks and NGO neurology programmes across twenty-plus export markets.
India is our origin, not our market. Levetiracetam is exported only, and because it is a maintenance therapy, the buyers who plan best are the ones placing the next order before the current one runs low, not after.
United Kingdom
NHS neurology and epilepsy-service pharmacy supply through wholesalers, and the MHRA (Medicines and Healthcare products Regulatory Agency) Specials / named-patient route for a strength not currently registered. Repeat-prescription continuity is the operative concern for a UK epilepsy formulary line, more than price alone.
GCC (UAE, KSA, Kuwait, Oman, Qatar, Bahrain)
Through licensed local importers, against hospital neurology-unit purchase orders and MoH tender award. CTD dossiers prepared for SFDA (Saudi Food & Drug Authority), MOHAP (UAE Ministry of Health and Prevention) and the GCC central registration route. Arabic patient information leaflet and destination-language cartons on file.
Nigeria, Kenya, Ghana, South Africa
Public-sector epilepsy-programme tenders and teaching-hospital neurology supply, through NAFDAC (Nigeria), PPB (Pharmacy and Poisons Board, Kenya) and SAHPRA (South African Health Products Regulatory Authority) routes. WHO Model List of Essential Medicines status supports Global Fund and NGO procurement pathways for epilepsy-treatment programmes.
Germany
Supply via licensed German importers under §72 AMG (Arzneimittelgesetz, the German Medicines Act), with Qualified Person certification on arrival. CTD dossier and Certificate of Pharmaceutical Product prepared for BfArM (German federal institute for drugs) recognition, German-language leaflet included.
IV-to-oral conversion, renal dosing, and why levetiracetam continuity is a clinical issue, not just a logistics one.
Levetiracetam is eliminated predominantly by renal excretion, largely as unchanged drug, so renal function materially affects clearance and dose adjustment in renal impairment is standard practice; the specific regimen is a prescribing decision set against creatinine clearance and local protocol, not something we specify here. The clinically useful fact for a hospital formulary is that oral bioavailability is close to 100%, so the IV concentrate and the oral tablet are interchangeable milligram for milligram, letting a patient move from IV to oral, or the reverse before a procedure, without a dose recalculation. The IV concentrate is diluted in a compatible infusion fluid per the product's own instructions before administration; it is not a vesicant, so extravasation is not the concern it is with cytotoxic infusions, though standard peripheral-line care still applies. Neither the tablet nor the IV form needs cold-chain handling, which matters for a therapy where the real supply risk is running out mid-course, not spoiling in transit. Hepatic impairment has little effect on levetiracetam clearance, unlike many older antiepileptics.
The documentation pack a neurology tender actually asks for.
Levetiracetam is a chronic therapy, so continuity of registration and supply matters as much as the initial dossier. We keep the paperwork current, not filed once and forgotten.
CTD Module 3
Full chemistry, manufacturing and controls section, eCTD-ready where the importing authority accepts it, with the Module 2 quality overall summary. Dissolution, assay and related-substances data per ICH Q6A, held current for repeat-order registration renewals, not just the first submission.
CoA and MoA, per batch
HPLC assay, related substances, uniformity of dosage units, dissolution and microbial limits, signed by the manufacturer's authorised QC head on every batch. Batch-to-batch consistency matters more for a maintenance antiepileptic than for a short-course medicine, since the same formulary is tracking the same product for years.
CoPP, WHO-GMP, MFG licence
Certificate of Pharmaceutical Product in WHO format, WHO-GMP certificate and manufacturing licence for the named Indian manufacturing site, issued by CDSCO (Central Drugs Standard Control Organization, India) and apostilled where the destination requires it. M Care is the exporting merchant named on the commercial documents; the manufacturing site is named on the regulatory ones.
Pack insert, labels, artwork
Destination-language patient information leaflet and carton labelling to local regulator convention. Calendar-blister marking supports adherence tracking for a chronic therapy, which formulary committees increasingly ask about at tender stage.
Temperature control
No cold-chain needed for the film-coated tablet. Standard ambient pharmaceutical freight, pre-shipment packaging checks and an on-arrival inspection record. The main continuity risk on an antiepileptic line is a gap between orders, not a temperature excursion in transit.
Pharmacovigilance
A named PV contact organised in the destination market on registration, Periodic Safety Update Reports compiled to ICH E2C. Behavioural and mood-related effects, the recognised class-level psychiatric signal for antiepileptics, remain a standard PSUR watch item alongside routine hypersensitivity reporting.
Complete the neurology formulary.
Epilepsy and wider neurology tenders rarely run on one molecule. We carry the broader CNS and neurology cluster alongside levetiracetam.
Risperidone
Second-generation (atypical) antipsychotic for schizophrenia and bipolar I mania, with a short-term aggression indication. 0.25mg to 6mg film-coated tablets from the M Care roster.
Amitriptyline
Tricyclic antidepressant, used for neuropathic pain and depression per destination-country labelling. Standard tablet strengths from 10mg to 50mg.
Citalopram
SSRI antidepressant, first-line for depression and generalised anxiety in many formularies. 10mg, 20mg and 40mg tablets, plus oral drops.
Donepezil
Cholinesterase inhibitor for Alzheimer's-type dementia, a common companion line on a neurology tender alongside an antiepileptic. 5mg and 10mg tablets.
Pregabalin
Gabapentinoid for neuropathic pain and generalised anxiety disorder, structurally unrelated to levetiracetam but frequently co-listed on the same formulary. 25mg to 300mg capsules.
All CNS & neurology →
1,311+ CNS and neurology SKUs: antiepileptics, antidepressants, antipsychotics and dementia therapy across the formulary.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Strength (250mg or 1000mg tablet, or another presentation you need sourced), pack format, destination market, buyer type (hospital neurology unit, MoH tender, wholesaler) and whether this is a new listing or a repeat order against an existing formulary.
- We route to the right line. Levetiracetam sits on the M Care roster at 250mg and 1000mg, with other strengths and the IV concentrate sourced against the specific enquiry from the wider Indian WHO-GMP manufacturer base. For a repeat order, we prioritise the line already registered in your market.
- Commercial and regulatory offer. FOB or CIF price, lead time, CoPP and CTD dossier status for the destination, and the documentation pack included. Inside one working day, with continuity of supply flagged explicitly for a chronic-therapy line.
- Order, produce, release, ship. QC release on the Indian side. Standard ambient freight, no cold-chain. In-transit tracking and an on-arrival inspection record on request, timed against your existing stock cover so a repeat order lands before the current pack runs out.
- After delivery. Batch records, CoA and shipment documentation archived for the consignment's full shelf life. Pharmacovigilance contact opened on registration, and we flag your likely next re-order window so a maintenance-therapy line does not run down to zero stock.
Levetiracetam supply, the specific questions.
What strengths of levetiracetam do you supply?
250mg and 1000mg film-coated tablets sit on the M Care roster today. Levetiracetam is also widely available worldwide as 500mg and 750mg tablets, an oral solution and a concentrate for solution for infusion for intravenous use; tell us the exact strength, form and destination market and we source it against your enquiry from the wider Indian WHO-GMP manufacturer base.
Why does IV-to-oral switching matter for a levetiracetam tender?
Levetiracetam has oral bioavailability close to 100%, so the intravenous concentrate and the oral tablet convert milligram for milligram. In practice, that means a hospital can start a patient on the IV form on admission and switch to the oral tablet as soon as they can swallow, without recalculating the dose. For a formulary committee, that is a genuine reason to hold both presentations of the same molecule rather than treating IV and oral as separate procurement decisions.
Why is continuity of supply such a big deal for an antiepileptic specifically?
Levetiracetam is a maintenance therapy: patients typically stay on it for years, and seizure control is often what stands between a patient and driving, working or living independently. An unplanned interruption is not a minor inconvenience, it risks breakthrough seizures. That is why we treat a levetiracetam enquiry as a supply-continuity conversation from the first message, flagging your likely re-order window rather than waiting for stock to run low before we hear from you.
Is levetiracetam on the WHO Essential Medicines List?
Yes. Levetiracetam is included on the WHO Model List of Essential Medicines as an antiepileptic option, including as an alternative where sodium valproate is unsuitable, for example in women of childbearing potential, given valproate's recognised teratogenic risk. That status supports Global Fund and NGO epilepsy-programme procurement pathways across the African and South-East Asian markets we ship into.
Does renal impairment change how you supply or document levetiracetam?
Levetiracetam is eliminated predominantly by the kidneys, largely as unchanged drug, so renal function affects clearance and dose adjustment in renal impairment is standard clinical practice. That is a prescribing decision for the clinician, set against the patient's renal function and local protocol; it does not change what we supply or document. We ship the same WHO-GMP-manufactured product regardless of the destination formulary's dosing protocol.
Which markets and buyers do you supply levetiracetam into?
UK NHS neurology and epilepsy-service pharmacy supply through wholesalers, GCC hospital tenders through licensed importers (Saudi Arabia via the SFDA, UAE via MOHAP, and the wider GCC via national bodies or the central registration route), African public-sector epilepsy-programme tenders (Nigeria's NAFDAC, Kenya's PPB, South Africa's SAHPRA), Germany under §72 AMG import, and importers across Latin America and South-East Asia through their national registration pathways. We do not supply into India. Full coverage is at markets.
What documentation is included with a levetiracetam consignment, and does it differ for a repeat order?
Every consignment ships with a batch-specific Certificate of Analysis, Method of Analysis, Certificate of Pharmaceutical Product where required, WHO-GMP certificate for the manufacturing site, CDSCO manufacturing licence, Certificate of Origin and destination-language leaflet and carton artwork. For a repeat order against an existing registration, the dossier itself does not need resubmitting, only the batch-specific documents change, which is part of why we recommend re-ordering before stock runs low rather than after.
Send the specifics. You'll have a price inside one working day.
Strength, form, volume, destination, and whether this is a new listing or a repeat order. For a chronic therapy, tell us your current stock cover too, so we can time the shipment before it runs low.